World News
-
Abbvie to acquire Allergan in a deal worth $63B
World | News | 0 Comment | 27 Jun, 2019
AbbVie and Allergan have announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction...Read more
-
FDA approves first treatment for chronic rhinosinusitis with nasal polyps
World | News | 0 Comment | 27 Jun, 2019
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis ...Read more
-
NIH launches large TB prevention trial
World | News | 0 Comment | 27 Jun, 2019
A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and eff...Read more
-
Medherant sets next clinical stage development by appointing John Burt as new CEO
World | News | 0 Comment | 27 Jun, 2019
Medherant Limited, the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Bu...Read more
-
Cobra Biologics, Symbiosis complete £4.8M viral vector supply chain collaboration
World | News | 0 Comment | 26 Jun, 2019
Cobra Biologics, an international contract development and manufacturing organisation (CDMO) focused on viral vector drug substance production, and Symbiosis Pharmaceutical Services (S...Read more
-
LabCorp, Mount Sinai HS to develop AI-enabled pathology CoE
World | News | 0 Comment | 26 Jun, 2019
LabCorp and the Mount Sinai Health System have announced another element in their shared goal of improving laboratory services and patient care. LabCorp, a life sciences company, and&n...Read more
-
New Multi-Partner Trust Fund launched to combat antimicrobial resistance globally
World | News | 0 Comment | 25 Jun, 2019
In a major boost to combat one of the gravest risks to global health a funding vehicle allowing partners to devote resources to accelerate global action against Antimicrobial Resistance (AM...Read more
-
Glenmark, Novartis to promote respiratory products in Brazil
World | News | 0 Comment | 24 Jun, 2019
Glenmark has announced that its Brazilian subsidiary, Glenmark Farmacêutica Ltda has entered into an exclusive partnership agreement with Novartis Biosciences S.A, a subsidiary of Nov...Read more
-
Parexel launches an enhanced integrated outsourcing delivery model for FSP
World | News | 0 Comment | 24 Jun, 2019
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through to Commercialization...Read more
-
World | News | 0 Comment | 24 Jun, 2019
Pfizer has announced that the European Commission approved TALZENNA (talazoparib), an oral poly (ADP-ribose) polymerase (PARP) inhibitor, as monotherapy for the treatment of...Read more
-
Canon Medical Showcases New Ultrasound Product Line at ASE 2019
World | News | 0 Comment | 24 Jun, 2019
Canon Medical Systems USA, Inc. is showcasing its innovative new line of ultrasound systems, the Aplio a-series, at this year’s American Society of Echocardiography (ASE) annual meeti...Read more
-
World | News | 0 Comment | 24 Jun, 2019
Vertex Pharmaceuticals Incorporated has announced that the U.S. Food and Drug Administration (FDA) approved SYMDEKO (tezacaftor/ivacaftor and ivacaftor) for use in children with cystic fibr...Read more
-
Agilent invests$185M in new facility to develop Oligos
World | News | 0 Comment | 24 Jun, 2019
Agilent Technologies Inc. has announced the opening of a production facility in Colorado that more than doubles its capacity to develop and manufacture "oligos," which are short DNA and RNA...Read more
-
Regeneron, Sanofi announce positive results for IL-33 antibody for asthma
World | News | 0 Comment | 21 Jun, 2019
Regeneron Pharmaceuticals and Sanofi have announced that a Phase 2 proof-of-concept trial evaluating the investigational IL-33 antibody REGN3500 (SAR440340) met the primary endpoi...Read more
-
PDS Biotechnology Corp gets U.S. and European patents for Versamune
World | News | 0 Comment | 21 Jun, 2019
PDS Biotechnology Corporation, a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced that the United ...Read more
-
Optum completes acquisition of DaVita Medical Group from DaVita
World | News | 0 Comment | 21 Jun, 2019
Optum, a leading health services company, completed its acquisition of DaVita Medical Group, one of the nation’s leading independent medical groups, from DaVita Inc. As part of the tr...Read more
-
Servier lays foundation stone for new research institute
World | News | 0 Comment | 21 Jun, 2019
Servier, an independent international pharmaceutical company, has laid the foundation stone of its future Research Institute in the Paris-Saclay cluster. The new Servier Paris-Saclay Resear...Read more
-
Edesa Biotech receives approval to proceed with its clinical investigation
World | News | 0 Comment | 20 Jun, 2019
Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration has notified the company that it may proceed with its clinical investi...Read more
